Abstract. The purpose of the study was to assess the efficacy of single photon emission computed tomography (SPECT) with 199 Tl and 99m
199
Tl SPECT. In the breast cancer patients, the increased 199 Tl uptake in the breast was visualized in 94.8% patients, Tc-MIBI-in 93.4% patients. The increased 199 Tl uptake in axillary lymph nodes was detected in 60% patients, and Tc-MIBI-in 93.1% patients. In patients with laryngeal/hypopharyngeal cancer, the sensitivity of SPECT with 199 Tl and 99m Tc-MIBI was 95%. The 199 Tl SPECT sensitivity in identification of regional lymph node metastases in the patients with laryngeal/hypopharyngeal cancer was 75% and the 99m Tc-MIBI SPECT sensitivity was 17%. The data obtained showed that SPECT with 199 Tl and 99m
Tc-MIBI can be used as one of the additional imaging methods in detection of tumors.
INTRODUCTION
According to the recent WHO data more than 10 million newly diagnosed cancer cases occur annually in the world. In many countries cancer ranks the second most common cause of death following cardiovascular diseases 0.
Nuclear medicine techniques have the advantage over X-ray or magnetic resonance imaging in terms of higher specificity with a similar high sensitivity for cancer detection [1] [2] [3] . Moreover, the use of nuclear medicine imaging in detection of laryngeal/hypopharyngeal tumors allows prevention of unnecessary diagnostic invasive procedures. T -methoxy-isobutyl-isonitrile ( 99m Tc-MIBI) is the most widely used single photon emission computed tomography (SPECT) tracer in detecting malignant disease [4, 5] . However, this tracer with a relatively high sensitivity has rather a low specificity. Therefore, the search for radiopharmaceuticals characterized by a high specificity while maintaining adequate sensitivity is of great importance.
More than 30 years ago the diagnostic value of 201 Tl for detecting malignant tumors was studied. It was shown that 201 Tl, a biological potassium analogue, accumulated actively in tumors [5] . The findings from animal studies demonstrated that 201 Tl had higher tumor accumulation compared to other radiopharmaceuticals [6, 7] . However, a long half-life (72 hours) of 201 Tl limited its widespread use, since there was a risk of increased radiation dose to the patient's body and critical organs, especially during re-examinations, for example during chemotherapy.
It is proposed that 199 Tl is a more promising isotope than 201 Tl, which is currently used in nuclear medicine. Unlike 201 Tl, 199 Tl has a simpler and cheaper production method. There are many reports on the use of this isotope for myocardial perfusion scintigraphy. Cellular uptake mechanism of 199 Tl is the same as that of 201 Tl. However, because of its short half-life (7.4 hours), the radiation dose to the patient's whole body and critical organs is 
MATERIALS AND METHODS
A total of 220 patients were included into the study. There were 120 women with breast disease. Out of them, 39 patients with stage T 1-4 N 0-2 M 0 breast cancer and 20 patients with benign breast lesions were injected with 199 Tl, and 61 patients with stage T 1-4 N 0-2 M 0 breast cancer were injected with Besides conventional imaging methods such as computed tomography, ultrasound, fibrolaryngoscopy and biopsy, all patients underwent preoperative SPECT with 199 l or 99m Tc-MIBI. The patients were subsequently operated on and surgical specimens were examined histologically and immunohistochemically. The patients with benign breast lesions underwent sectoral resection of the breast with subsequent histological examination.
Single photon emission computed tomography was performed using a double-head gamma-camera (E.CAM 180, Siemens) equipped with parallel high energy collimators for 199 l and parallel low energy collimators for Tc-MIBI at the dose of 740 MBq was made intravenously. In the patients with breast disease the injection was made into the antecubital vein contralaterally to the breast lesion or in the pedal vein. The images of the breast were obtained with the patients lying in the supine position with the arms raised over the head and with the chest, both breasts, axilla and the myocardium, included into the field of view. For obtaining SPECT images in the patients with laryngeal/hypopharyngeal cancer, the patients were also placed in a supine position, and the detector's field of the view encompassed the head and neck region and trachea to the bifurcation. A total of 32 projection images were recorded into a 64 64 matrix (30 seconds per projection), without a magnification factor. The scan images were analyzed using the manufacturer software (e.soft, Siemens, Germany). Three-dimensional images of the chest, sagittal, transverse and coronal sections were obtained. Single photon emission computed tomography scans were visually assessed. The images of contralateral areas were compared and asymmetrically increased radiotracer uptake was considered pathological.
RESULTS
Single photon emission computed tomography revealed no abnormal 199 Tl uptake in the chest wall and breasts of patients with benign breast lesions. Despite a small group of patients (n = 20), the specificity of SPECT with 199 Tl was 100%.
In breast cancer patients, the increased 199 Tl uptake was visualized in 37 (94.8%) of the 39 patients. Out of 6 patients with tumors less than 10 mm 4 showed abnormal radiotracer uptake (Fig. 1) . In one case, a large mass detected by mammography and ultrasound appeared as a cluster of microcalcifications. Carrying out SPECT with 99m Tc-MIBI revealed abnormal formations in the projection of the mammary glands in 59 (93.4%) out of 61 patients (Fig. 2) . Tumors greater than 10 mm were detected by 199 Tl and 99m
Tc-MIBI SPECT in 100% of cases. It is well known that a secondary infiltrative ductal breast carcinoma can be difficult to diagnose. In our study, the accuracy in differentiating malignant from benign breast lesions by SPECT with 199 Tl was 100%, as well as with Tc-MIBI (Figs. 3, 4) . Identification of multicentric breast cancer is an important factor in diagnosis of breast cancer. In our study, multicentric breast cancer was diagnosed in 66.6% of the patients during the study with 199 Tl and in 46.1% with 99m Tc-MIBI (Figs. 5, 6 ). As regard to lymph node involvement, the increased 199 Tl uptake in the axillary lymph nodes was observed in 15 out of 25 patients (60%) with histologically verified metastases (Fig. 7) . Only 2 out of 5 patients had abnormal radiotracer uptake in the pectoral and subclavicular lymph nodes (Fig. 8) . Thus, the 199 Tl SPECT sensitivity for the detection of metastatic regional lymph nodes in breast cancer patients was 60%.
It was possible to visualize the modified axillary lymph nodes in almost all the cases during the study with Tc-MIBI in axillary region was detected (Fig. 9) . In addition, pathological changes in the projection of pectoral lymph nodes, subclavian and subscapularis groups were detected in 5 patients. This technique allowed us to differentiate between different levels of lymph nodes (Fig. 10) . The sensitivity of the SPECT with 99m Tc-MIBI in identifying metastatic regional lymph nodes was 93.1%. The specificity of SPECT with 199 Tl was 100%, with 99m
Tc-MIBI-80%.
020011-3 Tc-MIBI abnormal uptake was detected in 95% of the patients with primary laryngeal/hypopharyngeal cancer (Figs. 11, 12 ). It should be noted that despite limitations for SPECT in visualization of tumors less than 10 mm. The minimum lesion size was 4 mm in the greatest dimension. In 20 out of 20 patients with recurrent laryngeal/hypopharyngeal cancer an abnormal uptake both 199 Tl and 99m Tc-MIBI was detected; it was 100% sensitivity of SPECT with 199 Tl and 99m
Tc-MIBI in the diagnosis of recurrent laryngeal/hypopharyngeal cancer.
The histological examination of specimens obtained by ultrasound-guided fine needle aspiration biopsy showed cervical lymph node metastases in 18.3% of cases. On SPECT the lymph nodes, affected by metastases, were visualized in the form of tracer hyperfixation focus of irregular shape with rough, indistinct boundaries, expressed by a nonuniform distribution of tracer, usually of low intensity. Tl could detect biopsy-proven lymph node metastases in 75% of cases (Fig. 13) . When performing SPECT with 99m Tc-MIBI we were able to identify the accumulation of the drug in the projection of lymph nodes, affected by metastases, in 2 (17%) out of 12 patients (Fig. 14) . We assume that such a low information content of SPECT with 99m
Tc-MIBI in the detection of metastases in regional lymph nodes is primarily related to their small size and physiological, initially high accumulation of 99m Tc-MIBI in the projection of the thyroid and submandibular salivary glands, which often screens the zones of the regional lymph collector (Fig. 15) . This effect is less pronounced when using 199 Tl (Fig. 16 ).
DISCUSSION
Our first experience of using 199 l has clearly indicated that this radiopharmaceutical represents a useful diagnostic tool for the detection of breast and laryngel/hypopharyngeal cancers. Single photon emission computed tomography with 199 l showed 100% specificity for detecting breast cancer, when compared to 99m
Tc-MIBI with reported specificity varying from 85% to 94% [5, 13] .
With regard to the assessment of regional lymph node metastasis in patients with laryngeal/hypopharyngeal cancer, 199 l SPECT demonstrated high specificity, whereas Tc-MIBI failed to evaluate the status of regional lymph nodes due to its physiological high uptake in the thyroid gland.
Despite the abovementioned advantages, 199 l has also disadvantages. This cyclotron-produced radiopharmaceutical has a higher cost compared to 99m Tc, the most widely used radioisotope in nuclear medicine. Moreover, our findings have demonstrated rather a low sensitivity in the detection of regional lymph node metastases in breast cancer patients, thus significantly impairing the diagnostic accuracy.
Anyway, 199 l is a promising radiopharmaceutical for the detection of malignant tumors; however, further studies are required to determine its role in the cancer diagnostic algorithm.
